For its third fiscal quarter (ending September 30), American Financial Group Inc (NYSE: AFG) has reported a 3% increase in E.P.S. from $2.10 a year ago to $2.16 in the current quarter. For the latest […]
Vishay Precision Group Inc (NYSE: VPG) has reported E.P.S. of $-0.10 for its third fiscal quarter (ending September 30) versus $0.46 for the same period a year ago — a decline of -122%. E.P.S. were […]
US Physical Therapy Inc (NYSE: USPH) has reported earnings for its third fiscal quarter (ending September 30) of $0.39 versus $0.51 for the same period a year ago — a decline of -24%. For the […]
TopBuild Corp (NYSE: BLD) has reported earnings for its third fiscal quarter (ending September 30) of $5.68 versus $5.30 for the same period a year ago — an increase of 7%. E.P.S. were $19.91 for […]
For its third fiscal quarter (ending September 30), Thomson Reuters Corp (NYSE: TRI) has reported a -25% decline in E.P.S. from $0.81 a year ago to $0.61 in the current quarter. E.P.S. were $4.94 for […]
Natural Resource Partners LP (NYSE: NRP) has reported E.P.S. of $2.04 for its third fiscal quarter (ending September 30) versus $3.40 for the same period a year ago — a decline of -40%. For the […]
For its third fiscal quarter (ending September 30), Louisiana-Pacific Corp (NYSE: LPX) has reported a -21% decline in E.P.S. from $1.63 a year ago to $1.28 in the current quarter. E.P.S. were $5.82 for the […]
Helios Technologies Inc (NYSE: HLIO) has reported E.P.S. of $0.34 for its third fiscal quarter (ending September 30) versus $0.11 for the same period a year ago — an increase of 209%. For the latest […]
Gartner Inc (NYSE: IT) has reported earnings for its third fiscal quarter (ending September 30) of $5.36 versus $2.28 for the same period a year ago — an increase of 135%. E.P.S. were $13.64 for […]
On 11/5/24, Flotek Industries Inc (NYSE: FTK) stock enjoyed a major increase of 23.0%, closing at $6.15. Moreover, trading volume in this advance was exceptionally high at 369% of normal. The stock has risen 25.5% […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research